N/A
N=22
Static Magnetic Therapy for Carpal Tunnel Syndrome
Carpal Tunnel Syndrome
Bottom Line
View on ClinicalTrials.gov: NCT02609113 ↗Enrolled (actual)
22
Serious AEs
0.0%
Results posted
Jan 2018
Primary outcome: Primary: Change in Boston Carpal Tunnel Questionnaire (BCTQ) Score at 6 Weeks — 48.6; 45.4 units on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Strong Magnetic Wristband (Device); Weaker Magnetic Wristband (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Wake Forest University Health Sciences
- Primary completion
- Oct 2016
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in Boston Carpal Tunnel Questionnaire (BCTQ) Score at 6 Weeks |
48.6; 45.4 | — |
| SECONDARY Change in Echogenicity (Hyper or Hypo) on the Median Nerve Ultrasound at 6 Weeks |
89; 89 | — |
| SECONDARY Change in Cross-sectional Area as Measured in mm2 on Median Nerve Ultrasound at 6 Weeks |
11.6; 14.2 | — |
| SECONDARY Change in Vascularity (Normal or Abnormal) as Measured on Median Nerve Ultrasound at 6 Weeks |
33; 33 | — |
Summary
The purpose of this research study is to investigate if magnet therapy is effective as an alternative therapy for CTS.
Eligibility Criteria
Inclusion Criteria
- Diagnosis of mild to moderate Carpal Tunnel Syndrome by history, clinical exam and Electromyography (EMG) study.
- ≥ 18 years
Exclusion Criteria
- Current use of magnets as therapy for Carpal Tunnel Syndrome
- Known allergy to silicone
- Unwillingness to wear wristband for 6 weeks
- Patients who have devices that may be affected by exposure to magnets such as vagal nerve stimulator, pacemaker or insulin pump.
Data sourced from ClinicalTrials.gov (NCT02609113). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.